These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Leveraging electronic health record data for pragmatic randomized trials. Roe MT Clin Trials; 2020 Aug; 17(4):368-369. PubMed ID: 32668979 [No Abstract] [Full Text] [Related]
3. Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity. Koehler M; Donnelly ET; Kalanovic D; Dagher R; Rothenberg ML Ann Oncol; 2016 Jul; 27(7):1342-8. PubMed ID: 27029709 [No Abstract] [Full Text] [Related]
4. Pros and cons of pragmatic clinical trials. Lurie JD; Morgan TS J Comp Eff Res; 2013 Jan; 2(1):53-8. PubMed ID: 24236521 [TBL] [Abstract][Full Text] [Related]
5. What we talk about when we talk about randomized controlled trials. Chetta A; Olivieri D Respiration; 2014; 87(1):9-10. PubMed ID: 24281333 [No Abstract] [Full Text] [Related]
6. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences. Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA; J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808 [TBL] [Abstract][Full Text] [Related]
8. Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product. Bibby AC; Torgerson DJ; Leach S; Lewis-White H; Maskell NA Trials; 2018 Jan; 19(1):18. PubMed ID: 29310706 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Pragmatism in Recently Published Randomized Clinical Trials. Janiaud P; Dal-Ré R; Ioannidis JPA JAMA Intern Med; 2018 Sep; 178(9):1278-1280. PubMed ID: 30039169 [TBL] [Abstract][Full Text] [Related]
10. Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial. Hartman L; Bos R; Buttgereit F; Güler-Yuksel M; Ionescu R; Kok MR; Lems WF; Micaelo M; Opris-Belinski D; Pusztai A; Santos E; Da Silva J; Szekanecz Z; Zeiner K; Zhang D; Boers M Scand J Rheumatol; 2019 Jul; 48(4):340-341. PubMed ID: 31132016 [No Abstract] [Full Text] [Related]
11. Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation. Eichler HG; Koenig F; Arlett P; Enzmann H; Humphreys A; Pétavy F; Schwarzer-Daum B; Sepodes B; Vamvakas S; Rasi G Clin Pharmacol Ther; 2020 Apr; 107(4):773-779. PubMed ID: 31574163 [TBL] [Abstract][Full Text] [Related]
12. Pragmatic study designs for older adults with cancer: Report from the U13 conference. Nipp RD; Yao NA; Lowenstein LM; Buckner JC; Parker IR; Gajra A; Morrison VA; Dale W; Ballman KV J Geriatr Oncol; 2016 Jul; 7(4):234-41. PubMed ID: 27197914 [TBL] [Abstract][Full Text] [Related]
13. Explanatory trials versus pragmatic trials. Sedgwick P BMJ; 2014 Nov; 349():g6694. PubMed ID: 25395503 [No Abstract] [Full Text] [Related]
14. Systematic review of intervention design and delivery in pragmatic and explanatory surgical randomized clinical trials. Blencowe NS; Boddy AP; Harris A; Hanna T; Whiting P; Cook JA; Blazeby JM Br J Surg; 2015 Aug; 102(9):1037-47. PubMed ID: 26041565 [TBL] [Abstract][Full Text] [Related]